Return to homepagePandemic Pact

Synthetic reconstruction of an attenuated SARS-CoV-2 virus for vaccine development and a high-content inhibitor screen

Grant number: IPA/2020/000091

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    SERB India

  • Principal Investigator

    Dr. Anand Kumar Bachhawat

  • Research Location

    India

  • Lead Research Institution

    Indian Institute of Science Education and Research, Mohali

  • Research Priority Alignment

    N/A

  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

New or repurposed antivirals against valid viral targets, viricidal coatings

1 Publication linked via Europe PMC

Last Updated:6 days ago

View all publications at Europe PMC

Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivo.